Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$93K Buy
+342
New +$106K 0.05% 149
2017
Q2
Sell
-1,000
Closed -$273K 617
2017
Q1
$273K Buy
1,000
+800
+400% +$226K 0.03% 270
2016
Q4
$52K Buy
+200
New +$59.3K ﹤0.01% 293

Other funds holding BIIB

FNY Partners Fund's BIIB Position: Q1 2018 in Review

FNY Partners Fund opened a new position in Biogen (BIIB) in Q1 2018: 342 shares worth $93K. The stake represents 0.05% of the portfolio and ranks #149 among its holdings. This is a return to the name: FNY Partners Fund previously reported a position in BIIB as recently as Q1 2017.

FNY Partners Fund first reported a position in BIIB in Q4 2016 and has held it in 3 quarters since. The position peaked at $273K in Q1 2017. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

  • FNY Partners Fund held 342 shares of Biogen worth $93K as of Q1 2018.
  • Biogen was a new FNY Partners Fund position in Q1 2018.
  • Biogen made up 0.05% of FNY Partners Fund's portfolio in Q1 2018, its #149 holding.
  • FNY Partners Fund first reported a position in Biogen in Q4 2016 and has held it in 3 quarters since.
  • FNY Partners Fund's Biogen position peaked at $273K in Q1 2017.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on FNY Partners Fund's 13F filing for Q1 2018, filed 18 Apr 2018.